Atlas FDA

t:slim X2 Insulin Pump with Basal-IQ Technology

FDA premarket approval P180008/S006 · decided 2018-10-26

Approval details

PMA number
P180008
Supplement
S006
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
t:slim X2 Insulin Pump with Basal-IQ Technology
Generic name
Automated insulin dosing , threshold suspend
Applicant
Tandem Diabetes Care, Inc.
Date received
2018-09-27
Decision date
2018-10-26
Days to decision
29 days
Decision code
OK30
Product code
OZO
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Change the procedure for wake button replacement during PCBA refurbishment by discontinuing replacement of the wake button if it meets specific criteria and by transferring various reprogramming steps in-house. The wake button switch assemblies are components of the t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM and the t:slim Insulin Pump with Basal-IQ Technology.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Control-IQ+ technology (K260429)Tandem Diabetes Care, Inc.2026-04-24
Tandem Mobi insulin pump with interoperable technology (K253074)Tandem Diabetes Care, Inc.2025-11-06
t:slim X2 insulin pump with interoperable technology (K250792)Tandem Diabetes Care, Inc.2025-09-24
Control-IQ+ technology (K250798)Tandem Diabetes Care, Inc.2025-05-21
Control-IQ+ technology (K243823)Tandem Diabetes Care, Inc.2025-02-24
Tandem Mobi Insulin Pump with interoperable technology (K241078)Tandem Diabetes Care, Inc.2024-07-26
Tandem Mobi insulin pump with interoperable technology (K240309)Tandem Diabetes Care, Inc.2024-03-21
t:slim X2 Insulin Pump with Interoperable Technology (K232380)Tandem Diabetes Care, Inc.2023-11-03